Answers are grounded in this paper and cite their sources.
The use of extracorporeal membrane oxygenation in the management of ARDS has grown considerably in the past decade, largely as a consequence of improvements in extracorporeal technology and management techniques. Recently published data has helped clarify the use of ECMO in ARDS, and its role in optimizing lung-protective ventilation and minimizing ventilator-induced lung injury has the potential to have a substantial impact on ARDS management and outcomes. In the future, novel extracorporeal management strategies may lead to a new paradigm in our approach to patients with ARDS.
No takes yet. Share an insight, caveat, or question.
Parekh et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: